Group 1 - The company has established a wholly-owned subsidiary, Guizhou Zhongdao Traditional Chinese Medicine Health Technology Co., Ltd., with an investment of 10 million RMB to enhance its pharmaceutical industry layout and accelerate the research and development of health food [1][2] - The subsidiary is registered with a capital of 10 million RMB and will focus on various health food production and sales, including special medical purpose formula foods and infant formula foods [1][2] - This investment aligns with the company's strategic development plan to improve its diversified product matrix and aims to enhance overall profitability and risk resistance [1][2] Group 2 - The establishment of the subsidiary is not expected to harm the interests of the company or its shareholders and will not negatively impact the company's operations [2] - The company plans to conduct its business activities prudently and in compliance with regulations, aiming for favorable investment returns while being aware of potential market and policy risks [2]